-
Pancreatic Cancer, Immunotherapy, and PRINCE: An Interview with Vanessa Lucey, PhD, MBA
We spoke with Vanessa M. Lucey, PhD, MBA, about challenges of treating pancreatic cancer and promising combination therapy…
-
Meet Dr. Amanda Lund, One of the New CRI Lloyd J. Old STARs
We spoke with Dr. Amanda Lund to learn more about her work and what she hopes to…
-
Meet Dr. Alexander Marson, One of CRI’s New Lloyd J. Old STARs
We spoke with Dr. Alexander Marson to learn more about his work and what he hopes to…
-
PORTER Immunotherapy Clinical Trial for Prostate Cancer Unveiled at SITC2019
Details of a promising new CRI co-funded clinical trial for metastatic prostate cancer unveiled at the 2019…
-
CICON19 Day 4 Update: Metabolic Crosstalk and the Microbiome
Day 4 of CICON19 highlighted breakthroughs in our understanding of the metabolic crosstalk within the tumor microenvironment as…
-
CICON19 Day 3 Update: Vaccines and Tumor Antigens, Technology and Informatics, and the Tumor Microenvironment
Day 3 of CICON19 explored current strategies to identify tumor neoantigens and develop vaccines as well as advances…
-
CICON19 Day 1 Update: Cancer Prevention and Combination Immunotherapy Strategies
Day 1 of CICON19 explored how checkpoint immunotherapy might be improved through combination strategies as well as…
-
Documentary Highlights Life and Work of CRI’s Dr. James Allison, 2018 Nobel Laureate
A new documentary on the life and work of Dr. James Allison, 2018 Nobel Prize winner and…
-
How Immunotherapy is Impacting Pediatric Cancer
We spoke with Susanne Baumeister, MD, about the current treatment landscape in childhood cancer, including immunotherapy and…
